rofecoxib: Clinical Trials

5 trials of rofecoxib, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 terminated. 5 Phase 2, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 25Completed 4, Terminated 1
Phase 33Completed 2, Terminated 1

Follow rofecoxib: new trials by email Literature Review of rofecoxib trials Research Report on rofecoxib

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Coxib-inhibition of Duodenal Polyp Growth in FAP
Rofecoxib, placebo - Duodenal Polyposis
Phase 2 / Phase 3TerminatedOslo University Hospital382003-09-012011-07-06
Study of Rofecoxib and Prolonged Constant Infusion of Gemcitabine in the Polychemotherapy Treatment of Advanced NSCLC
gemcitabine, prolonged continuous infusion gemcitabine, cisplatin - Advanced Non-small Cell Lung Cancer
Phase 2 / Phase 3CompletedNational Cancer Institute, Naples4002003-01-012023-03-23
Rofecoxib and Bupivacaine to Prevent Pain After Third Molar (Wisdom Tooth) Extraction
Rofecoxib and Bupivacaine - Pain, Tooth Extraction
Phase 2CompletedNational Institute of Dental and Craniofacial Research (NIDCR)1362002-12-012008-03-04
Rofecoxib to Prevent Pain After Third Molar (Wisdom Tooth) Extraction
Rofecoxib - Pain
Phase 2CompletedNational Institute of Dental and Craniofacial Research (NIDCR)1502001-11-012008-03-04
A Multicenter Trial of Rofecoxib and Naproxen in Alzheimer's Disease (NSAID Study)
Rofecoxib, Naproxen - Alzheimer Disease
Phase 2 / Phase 3CompletedNational Institute on Aging (NIA)2009-12-11

Conditions studied

Hyperalgesia (2)  ·  Pain (2)  ·  Alzheimer Disease (1)

Sponsors

National Institute of Dental and Craniofacial Research (NIDCR) (2)  ·  National Cancer Institute, Naples (1)  ·  National Institute on Aging (NIA) (1)  ·  Oslo University Hospital (1)

Countries

United States (3)  ·  Italy (1)  ·  Norway (1)

Top investigators

Cesare Gridelli, M.D. (1)  ·  Francesco Perrone, M.D., Ph.D. (1)  ·  Leon Thal, MD (1)

Results publications

PMID 12783912, PMID 17513173, PMID 25624439